Spero Therapeutics, Inc.·4

Jan 5, 4:14 PM ET

VINK PATRICK V.J.J. 4

4 · Spero Therapeutics, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-03$1.29/sh+15,471$19,95815,471 total
    Exercise: $1.74Exp: 2033-01-03Common Stock (15,471 underlying)
Footnotes (2)
  • [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
  • [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $20,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION